efficacy safety chlorella supplementation adults chronic hepatitis virus infection abstract aim evaluate safety efficacy chlorella num patients chronically infected hepatitis virus hcv genotype num methods eighteen adults chronic infection hcv genotype num received daily oral supplementation chlorella num wk rna levels hcv aspartate aminotransferase ast alanine aminotransferase alt levels evaluated treatment period paired tests conducted compare means variables beginning end study side effects quality life aspects compared weeks num num study period results majority num patients significant decrease alt levels week num week num evaluation side effects showed chlorella tolerated quality life assessment showed num participants reported improvement energy levels num reported improvement perception general health num showed decrease ast levels statistically significant patients exhibited improvement alt ast levels showed tendency decreased hcv viral load hcv rna levels showed decrease num patients ast/alt ratios week num week num results statistically significant conclusion chlorella supplementation tolerated patients chronic hcv significant decrease alt liver enzyme levels 
